PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
60.35%
G&A growth above 5% signals concerning overhead expansion. Seth Klarman would demand justification for increased costs.
No Data
No Data available this quarter, please select a different quarter.
117.22%
Other expenses growth above 20% signals concerning cost expansion. Seth Klarman would scrutinize unusual items.
89.95%
Operating expenses growth above 10% signals concerning cost expansion. Seth Klarman would demand justification.
89.95%
Total costs growth above 5% signals concerning expansion. Seth Klarman would demand justification.
-4.24%
Negative interest expense growth needs verification. Benjamin Graham would examine debt reduction strategy.
100.53%
D&A growth above 10% signals heavy asset expansion. Seth Klarman would demand evidence of future payoff.
79.29%
EBITDA growth above 15% demonstrates exceptional operating performance. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
-95.43%
Negative operating income growth needs thorough analysis. Benjamin Graham would examine operational issues.
No Data
No Data available this quarter, please select a different quarter.
-104.55%
Negative other expenses growth needs verification. Benjamin Graham would examine sustainability.
-100.00%
Negative pre-tax income growth needs thorough analysis. Benjamin Graham would examine operational issues.
No Data
No Data available this quarter, please select a different quarter.
-15.40%
Negative tax expense growth needs verification. Benjamin Graham would examine sustainability.
-134.36%
Negative net income growth needs thorough analysis. Benjamin Graham would examine operational issues.
No Data
No Data available this quarter, please select a different quarter.
-134.21%
Negative EPS growth needs thorough analysis. Benjamin Graham would examine operational issues.
-134.21%
Negative diluted EPS growth needs thorough analysis. Benjamin Graham would examine operational issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.